Vident Advisory, LLC Novo Nordisk A S Transaction History
Vident Advisory, LLC
- $4.8 Trillion
- Q1 2024
A detailed history of Vident Advisory, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Vident Advisory, LLC holds 31,522 shares of NVO stock, worth $4.49 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
31,522
Previous 30,264
4.16%
Holding current value
$4.49 Million
Previous $3.13 Billion
29.28%
% of portfolio
0.08%
Previous 0.08%
Shares
4 transactions
Others Institutions Holding NVO
# of Institutions
1,861Shares Held
310MCall Options Held
5.29MPut Options Held
4.93M-
Jennison Associates LLC21.1MShares$3 Billion1.82% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.7MShares$1.95 Billion0.83% of portfolio
-
Bank Of America Corp Charlotte, NC13.1MShares$1.86 Billion0.16% of portfolio
-
Morgan Stanley New York, NY12MShares$1.71 Billion0.13% of portfolio
-
Fayez Sarofim & CO Houston, TX11.8MShares$1.68 Billion4.6% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $321B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...